AstraZeneca, Bristol Myers Squibb Hold Preliminary USD 400 Billion Merger Talks: Report Written By sheeba farhat4 Aug 2026 6:35 PM ISTNew York: AstraZeneca Plc and Bristol Myers Squibb held preliminary discussions about a possible combination that would create one of the world's...
Indian Pharma Must Reduce US Dependence Amid Proposed Generic Drug Tariffs: Experts Written By sheeba farhat27 July 2026 10:51 PM ISTNew Delhi: India's pharmaceutical industry should treat the proposed US tariffs on imported generic medicines as a wake-up call to reduce dependence...
Trump Announces 0% Tariff on Generic Drugs Till 2028, 200% Duty Thereafter Written By sheeba farhat23 July 2026 10:21 PM ISTWashington: President Donald Trump said on Tuesday all generic drugs being brought into the U.S. will continue having a tariff of 0% for two years...
Eli Lilly in Talks to Acquire Psychedelic Drugmaker AtaiBeckley: Bloomberg Report Written By MD Bureau16 July 2026 6:35 PM ISTNew Delhi: Eli Lilly is in talks to acquire psychedelic drugmaker AtaiBeckley and a deal could be announced as soon as this week, Bloomberg News...
USFDA Chief Marty Makary Resigns Amid Trump Clash Over Flavoured Vapes, Drug Decisions Written By MD Bureau13 May 2026 8:28 PM ISTNew Delhi: The U.S. FDA Commissioner Marty Makary resigned, President Donald Trump said on Tuesday, after weeks of clashing with top White House and...
Trump Signs Off on Plan to Remove USFDA Commissioner Marty Makary: Report Written By sheeba farhat9 May 2026 4:06 PM ISTBengaluru: The White House signed off on a plan to fire U.S. Food and Drug Administration Commissioner Marty Makary, according to sources familiar...
Trump Warns Pharma Firms of 5-8% Extra Tariffs Ahead of October Drug Pricing Deadline Written By Parthika Patel3 Oct 2025 7:23 PM ISTNew Delhi: US President Donald Trump has issued a stern warning to pharmaceutical companies, cautioning that an additional 5-8% tariff will be levied...
Sun Pharma exposed to some headline risk amid US tariff move, but with limited earnings impact Written By Ruchika Sharma29 Sept 2025 4:48 PM ISTNew Delhi: The US government's recent decision to impose a 100 percent tariff on imports of branded and patented pharmaceutical products starting...
India's generic drugs safe as Trump targets branded pharma imports: Experts Ruchika Sharma27 Sept 2025 6:41 PM ISTNew Delhi: US President Donald Trump's recent decision to impose a 100 percent import tariff on branded and patented pharmaceutical products...
India targets new markets for pharma export growth amid US tariffs concerns Ruchika Sharma2 Sept 2025 5:05 PM ISTIndia is planning to boost its pharmaceutical exports to Russia, Brazil, and the Netherlands, according to two industry sources familiar with the...
Trump signs executive order to lower US drug prices Ruchika Sharma13 May 2025 3:30 PM ISTU.S. President Donald Trump has signed a broad executive order directing drugmakers to cut medicine prices to match those charged in other...
"Who's going to pay price to bring back manufacturing in US", asks Biocon MD Ruchika Sharma15 April 2025 10:30 AM ISTNew Delhi: Siddharth Mittal, the CEO and Managing Director of Biocon Limited, raised a critical question on Friday, asking who would bear...
